Nevertheless, the precise pathway through which the NLRP3 inflammasome impacts atherosclerosis is elusive; hence, comprehending the inflammasome activation pathways is pivotal for developing innovative targeted and efficient treatments [27]. The gene discussed is NLRP3; the disease is atherosclerosis.